Your browser doesn't support javascript.
loading
The In Vivo Selection Method in Breast Cancer Metastasis.
Nakayama, Jun; Han, Yuxuan; Kuroiwa, Yuka; Azuma, Kazushi; Yamamoto, Yusuke; Semba, Kentaro.
Afiliação
  • Nakayama J; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Han Y; Department of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo 162-8480, Japan.
  • Kuroiwa Y; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Azuma K; Department of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo 162-8480, Japan.
  • Yamamoto Y; Department of Life Science and Medical Bioscience, School of Advanced Science and Engineering, Waseda University, Tokyo 162-8480, Japan.
  • Semba K; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Int J Mol Sci ; 22(4)2021 Feb 14.
Article em En | MEDLINE | ID: mdl-33672831
ABSTRACT
Metastasis is a complex event in cancer progression and causes most deaths from cancer. Repeated transplantation of metastatic cancer cells derived from transplanted murine organs can be used to select the population of highly metastatic cancer cells; this method is called as in vivo selection. The in vivo selection method and highly metastatic cancer cell lines have contributed to reveal the molecular mechanisms of cancer metastasis. Here, we present an overview of the methodology for the in vivo selection method. Recent comparative analysis of the transplantation methods for metastasis have revealed the divergence of metastasis gene signatures. Even cancer cells that metastasize to the same organ show various metastatic cascades and gene expression patterns by changing the transplantation method for the in vivo selection. These findings suggest that the selection of metastasis models for the study of metastasis gene signatures has the potential to influence research results. The study of novel gene signatures that are identified from novel highly metastatic cell lines and patient-derived xenografts (PDXs) will be helpful for understanding the novel mechanisms of metastasis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ensaios Antitumorais Modelo de Xenoenxerto / Modelos Animais de Doenças Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Ensaios Antitumorais Modelo de Xenoenxerto / Modelos Animais de Doenças Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article